News Roche to file Actemra in inflamed artery disease Drug successful in late stage trial for giant cell arteritis
News Novartis drug gets fast US review in AML Midostaurin also under review in rare disease systemic mastocytosis
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
